Orally active bronchospasmolytic compounds and their preparation
US3937838A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jun 21, 1973 |
| Grant date | Feb 10, 1976 |
| Priority date | — |
| Expiry date | Jun 21, 1993 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C45/63
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds are disclosed having useful activity as bronchodilators of improved longevity of action and reduced incidence of side effects. These compounds are described by the formula: ##EQU1## wherein R.sub.1 is a member of the class consisting of tertiary butyl and cyclobutyl, and R.sub.2 is a hydrogen or 2 to 5 carbon atom acyl radical, and pharmaceutically acceptable salts thereof. The activity of these compounds is compared to previously known bronchodilators such as 1-(3', 5'-dihydroxyphenyl)-2-(isopropylamino)-ethanol, having the common name orciprenaline, and 1-(3', 4'-dihydroxyphenyl-2-isoproplyamino-ethanol, having the common name isoprenaline.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.